SCHEMBL6253963

SCHEMBL6253963

CCCCn1cc(C#N)c(N)n1.Cn1cc(C#N)c(N)n1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.40
TLR8 Q9NR97 1/20 0.39
TLR7 Q9NYK1 1/20 0.39
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ADORA2A P29274 2/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
GRK6 P43250 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4760124 0.94 KDR (0.43) KDRTLR8TLR7KDM4EMEN1
SCHEMBL2076920 0.89 KDR (0.49) KDRTLR8TLR7KDM4EMEN1
SCHEMBL1741589 0.88 KDR (0.51) KDRTLR8TLR7KDM4EMEN1
SCHEMBL1740452 0.88 KDR (0.51) KDRTLR8TLR7KDM4EMEN1
SCHEMBL1742916 0.88 KDR (0.51) KDRTLR8TLR7KDM4EMEN1
SCHEMBL1741794 0.88 KDR (0.51) KDRTLR8TLR7KDM4EMEN1
SCHEMBL8012441 0.88 TLR8 (0.42) TLR8TLR7MEN1TSHRKMT2A
SCHEMBL2075690 0.84 KDR (0.36) KDRTLR8TLR7KDM4EMEN1
SCHEMBL174802 0.82
SCHEMBL4338327 0.78 KDR (0.40) KDRTLR8TLR7KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1499614-A4 ADENOSINE A3 RECEPTOR MODULATORS KING PHARMACEUTICALS RES & DEV (US) 2005-08-24 EP disclosed
EP-1499614-A1 ADENOSINE A3 RECEPTOR MODULATORS King Pharmaceuticals Research and Development Inc. (US) 2005-01-26 EP disclosed
WO-2003095457-A1 ADENOSINE A3 RECEPTOR MODULATORS KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. (US) 2003-11-20 WO disclosed